GNTA
Genenta Science S.p.A.
NASDAQ · Healthcare · Biotechnology · IT
$0.96
+1.43%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.83x
- Price / sales
- —
- Price / cash flow
- -2.87x
Enterprise value
- Enterprise value
- $22.6M
- EV / sales
- —
- EV / EBITDA
- -1.30x
- EV / EBIT
- -1.19x
- Market cap
- $46.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025